Therapeutics News and Research

RSS

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

Exploring the connection between Parkinson's disease and gut microbiota to uncover potential therapeutic targets

Scientists have published a new review focusing on the relationship between PD and gut microbiota.

15 Jul 2022

Neuroscience simulations at NERSC reveal the origin of the cortical surface electrical signals

Where does electrical activity recorded on the surface of the brain come from, and what exactly determines which electrical signals get recorded?

14 Jul 2022

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

The Mark Foundation for Cancer Research announced eight outstanding research projects to receive its latest class of ASPIRE awards.

14 Jul 2022

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

The COVID-19 pandemic pushed back years of progress made in combating antimicrobial resistance (AR) in the United States.

14 Jul 2022

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Effective and safe treatments are needed for medulloblastoma - the most common type of cancerous brain tumor in children - especially for patients whose cancer has spread to the spinal cord.

14 Jul 2022

Bacterial species known for causing diarrheal infections may also drive colorectal cancer

Data collected by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy suggest that Clostridioides difficile, or C. diff, a bacterial species well known for causing serious diarrheal infections, may also drive colorectal cancer.

14 Jul 2022

The successful transplantation of genetically engineered pig hearts into recently deceased humans

Researchers successfully transplanted two genetically engineered heart pigs into recently deceased humans in June and July 2022.

14 Jul 2022

Age-related increases in brain inflammation may link Alzheimer's disease risk with sleep disturbance

A multisite research team from the University of California, Irvine, the University of Wisconsin–Madison and Wake Forest University has discovered that brain inflammation may link Alzheimer's disease risk with sleep disturbance, which may aid early detection and prevention efforts by identifying novel treatment targets at preclinical stages.

13 Jul 2022

Using microparticles to create 'self-boosting' vaccines

Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated.

13 Jul 2022

New center aims to accelerate research into biomarkers of neurodegenerative diseases

A new center established at Washington University School of Medicine in St. Louis aims to accelerate research into biomarkers of neurodegenerative conditions such as Huntington's and Parkinson's diseases, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and the so-called tauopathies, a group that includes Alzheimer's disease along with rarer diseases such as frontotemporal dementia, corticobasal syndrome and progressive supranuclear palsy.

13 Jul 2022

MaxCyte signs strategic platform license with LG Chem to advance its allogeneic CAR-T programs

MaxCyte, Inc., a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today announces the signing of a strategic platform license (SPL) with LG Chem Ltd., a globally diversified chemical company established in petrochemical, advanced materials and bio-technology, aiming to create new value for its customers based on science.

From MaxCyte, Inc. 13 Jul 2022

What are the biological features, prevention and control strategies against monkeypox?

Researchers elucidated the epidemiology and clinical presentation, biological features, pathogenicity and prevention and control strategies for monkeypox virus (MPXV) infections.

13 Jul 2022

Production of anti-SARS-CoV-2 antibodies from hyperimmunized chickens

A new study reports the production of neutralizing antibodies against SARS-CoV-2 in hyperimmunized hens.

12 Jul 2022

Researchers receive $3.25 million NIH grant to better understand the oral manifestations of HIV

Researchers at the Case Western Reserve University School of Dental Medicine will use a $3.25 million grant from the National Institutes of Health (NIH) to better understand how HIV impacts the human body, from mouth lesions to oral cancer.

11 Jul 2022

Study assesses the potential of plant secondary metabolites as potential anti-COVID-19 agents

A new study has focused on identifying plant secondary metabolites (PSM) having a higher affinity for S-RBD of SARS-CoV-2.

11 Jul 2022

ASN paper highlights the strengths, limitations of research methods used in nutrition science

The American Society for Nutrition highlights the value that all methodologies used in nutrition research contribute to the discipline, and that all methodologies, when used and interpreted appropriately, contribute to the evidence base.

8 Jul 2022

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Kidney cancer accounts for only 4% of all cancers in the United States; however, its incidence has more than doubled since 1975, with the most common type being clear cell renal cell carcinoma.

8 Jul 2022

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

A recent study published in the Science journal depicted that mosaic receptor-binding domain (RBD) nanoparticles immunize from diverse sarbecovirus challenges, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), among animal models.

8 Jul 2022

Global health campaigners disappointed with WTO deal to waive some patent rules on vaccine exports

A decision by the World Trade Organization (WTO) to waive certain intellectual property (IP) rules in order to widen access to COVID-19 vaccines has been met with disappointment by global health campaigners.

7 Jul 2022

Therapeutics News and Research

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Exploring the connection between Parkinson's disease and gut microbiota to uncover potential therapeutic targets

Neuroscience simulations at NERSC reveal the origin of the cortical surface electrical signals

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Bacterial species known for causing diarrheal infections may also drive colorectal cancer

The successful transplantation of genetically engineered pig hearts into recently deceased humans

Age-related increases in brain inflammation may link Alzheimer's disease risk with sleep disturbance

Using microparticles to create 'self-boosting' vaccines

New center aims to accelerate research into biomarkers of neurodegenerative diseases

MaxCyte signs strategic platform license with LG Chem to advance its allogeneic CAR-T programs

What are the biological features, prevention and control strategies against monkeypox?

Production of anti-SARS-CoV-2 antibodies from hyperimmunized chickens

Researchers receive $3.25 million NIH grant to better understand the oral manifestations of HIV

Study assesses the potential of plant secondary metabolites as potential anti-COVID-19 agents

ASN paper highlights the strengths, limitations of research methods used in nutrition science

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

Global health campaigners disappointed with WTO deal to waive some patent rules on vaccine exports

Next-generation therapeutics eBook eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News